NCT07239102 2025-11-20
Firmonertinib in the Treatment of EGFR(+) NSCLC Patients With Central Nervous System Metastasis
Beijing Tiantan Hospital
Completed
Clinical Trials
10 trialsNCT07005791 2025-06-05
AI-Based Ultrasound Prediction Model for Intracranial Pressure and Prognosis in Lung Cancer Patients With Leptomeningeal Metastasis: A Dual-Center Study
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
Not yet recruiting
NCT06718972 2025-04-27
CLM-tree datab
Guangzhou Medical University
Recruiting
NCT06705049 2024-11-26
Retrospective Study on Leptomeningeal Metastasis of Solid Tumors
Shanghai Zhongshan Hospital
Enrolling by invitation
NCT06417710 2024-05-16
NANO-LM
University of Zurich
Recruiting
NCT06410040 2024-05-10
A Retrospective Study of the Efficacy and Safety of Lolatinib in ALK+ NSCLC Patients With Brain or Meningeal Metastasis
Sichuan Cancer Hospital and Research Institute
Active not recruiting
NCT06399926 2024-05-06
Efficacy and Safety of Intraventricule Pemetrexed Disodium Administered Via Ommaya Reservoir
Xiangya Hospital of Central South University
Recruiting
NCT02071056 2020-08-18
Circulating Tumor DNA in Cerebrospinal Fluid as an Early Biomarker of Leptomeningeal Metastasis (LM)
Dartmouth-Hitchcock Medical Center
Completed
NCT02607605 2017-10-26
ctDNA
Sun Yat-sen University
Unknown
NCT02803619 2016-06-17
A Multi-center Prospective Observational Biomarker Study on EGFRm+ Non-small Cell Lung Cancer Patients With Leptomeningeal Metastasis
Peking Union Medical College Hospital
Unknown